TRACK BRANDS ON AI
Monitor your brand, company, or product's online reputation in AI responses
Searching...
Loading...
It's taking longer than usual, we might be experiencing higher load.
Give it a few more seconds or try again in a moment.
Give it a few more seconds or try again in a moment.
Searching...
Loading...
What does AI know about Alnylam Pharmaceuticals Inc?
What does OpenAI free version (gpt-3.5-turbo) know about Alnylam Pharmaceuticals Inc?
| Last request | 23.11.2023 |
| Well Known | Yes |
| Description | Alnylam Pharmaceuticals Inc is a biopharmaceutical company focused on discovering, developing, and commercializing novel therapeutics based on RNA interference (RNAi). |
| Most Notable Achievements | Alnylam has developed a pipeline of investigational RNAi therapeutics for the treatment of a wide range of diseases. |
| The Most Negative Fact | Alnylam has yet to receive FDA approval for any of its products. |
| Competition | None |
| Share with friends |
Register your email below to unlock features!
Don't like the AI answers? Who can help me Change them?
What does OpenAI paid version (gpt-4) know about Alnylam Pharmaceuticals Inc?
| Request date | |
| Well Known | Yes |
| Description | Alnylam Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing RNA interference (RNAi) therapeutics for the treatment of genetic and rare diseases. |
| Most Notable Achievements | Alnylam Pharmaceuticals Inc has received FDA approval for their RNAi therapeutic drug, ONPATTRO, which is the first and only treatment for hereditary transthyretin-mediated amyloidosis (hATTR). |
| The Most Negative Fact | Alnylam Pharmaceuticals Inc has faced criticism for the high cost of their RNAi therapeutics, which can be upwards of $450,000 per year. |
| Competition | None |
| Share with friends |
What does Google AI (PaLM) know about Alnylam Pharmaceuticals Inc?
| Last request | 21.12.2023 |
| Well Known | yes |
| Description | Alnylam Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Cambridge, Massachusetts, United States. |
| Most Notable Achievements | Alnylam Pharmaceuticals Inc. is a biopharmaceutical company that focuses on RNA interference (RNAi) therapeutics. |
| The Most Negative Fact | Alnylam Pharmaceuticals Inc. has been criticized for its high cost of drugs. |
| Competition | None |
What does Microsoft Bing AI know about Alnylam Pharmaceuticals Inc?
| Well Known | Yes |
| Description | liAmb Ndn,anocela dn rsigacR oegaai emR ec d pe cmnotyvcur gr uer,anoamainel tiianps yivrAehziauc)oNa er(a lcoend Iiecselevtcatnich Ausmrfe .ohecli cm tnfiipobonpdlnsPs |
| Most Notable Achievements | gd ainndsicsvnetve es hmtdnifai e a Ness ia eeeoesd rffnhpeRei. aerye iirfattnaauAtlew topAoa gemrhltl alltooi opp |
| The Most Negative Fact | plvdmyo o of esrtc ivAeFyohryttalDe sin o. saulr tprncaAe fapa |
| Competition | oenN |
Register your email below to unlock features!
Looks like you haven't registered an account yet?
Just search for a brand, person or top-list BELOW and register your email on the search results page:
